Cargando…
The USER Study: A Chart Review of Patients Receiving a 0.2 µg/day Fluocinolone Acetonide Implant for Diabetic Macular Edema
INTRODUCTION: To determine anatomical, functional, and intraocular pressure (IOP) responses to diabetic macular edema (DME) treatments pre- and post-0.2 µg/day fluocinolone acetonide (FAc) implant administration compared with baseline and the preceding 3 years. METHODS: This was a retrospective, cha...
Autores principales: | Eaton, Alexander, Koh, Sean S., Jimenez, Jaime, Riemann, Christopher D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393252/ https://www.ncbi.nlm.nih.gov/pubmed/30560505 http://dx.doi.org/10.1007/s40123-018-0155-5 |
Ejemplares similares
-
Real-World Outcomes in Diabetic Macular Edema for the 0.2 µg/Day Fluocinolone Acetonide Implant: Case Series from the Midlands, UK
por: Mushtaq, Bushra, et al.
Publicado: (2021) -
Effectiveness of 190 µg Fluocinolone Acetonide and 700 µg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis
por: Zarranz-Ventura, Javier, et al.
Publicado: (2020) -
Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study
por: Mansour, Sam E, et al.
Publicado: (2021) -
Clinical impact of the 0.2 µg/day fluocinolone acetonide intravitreal
implant: outcomes from the ILUVIEN(®) clinical evidence study in
Portugal
por: Carneiro, Angela, et al.
Publicado: (2020) -
Efficacy of 0.2 μg/day fluocinolone acetonide implant (ILUVIEN) in eyes with diabetic macular edema and prior vitrectomy
por: Meireles, A, et al.
Publicado: (2017)